Dana-Farber, Brigham and Women’s Cancer Center certified to offer new CAR T-cell therapy – News-Medical.net
News-Medical.net |
Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy
News-Medical.net Following a successful clinical trial involving Dana-Farber Cancer Institute and Brigham and Women's Hospital, the first chimeric antigen receptor (CAR) T-cell therapy for adult cancers was approved by the Food and Drug Administration (FDA) today. |
